Figure 4
Normalization of platelet counts and heparin-induced thrombocytopenia testing results in a patient with MGTS treated with daratumumab, bortezomib, and dexamethasone8

Normalization of platelet counts and heparin-induced thrombocytopenia testing results in a patient with MGTS treated with daratumumab, bortezomib, and dexamethasone8 

Abbreviations: DVd, daratumumab, bortezomib, and dexamethasone; DVT, deep venous thrombosis; ICH, intracranial hemorrhage; IVIg, intravenous immunoglobulin; PE, pulmonary embolism.

Reprinted with permission

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal